Format

Send to

Choose Destination
Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26.

Abolishing the 1-year rule: How much evidence will be enough?

Author information

1
Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada.
2
Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany.
3
Penn Neurological Institute, Philadelphia, Pennsylvania, USA.
4
Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
5
Department of Neurology, The Mount Sinai Hospital, New York, New York, USA.
6
Department of Neurology, Philipps University of Marburg, Marburg, Germany.
7
Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA.
8
Department of Neurosciences, UC San Diego, La Jolla, California, USA.
9
Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada.
10
Neuroscience Research Australia & University of NSW, Randwick, Australia.
11
Rush University Medical Center, Chicago, Illinois, USA.
12
Hopital De La Salpetriere, Paris, France.
13
Xuanwu Hospital of Capitol of Medical University, Beijing, People's Republic of China.
14
Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands.
15
The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
16
Department of Neurology, Christian-Albrechts University, Kiel, Germany.
PMID:
27666574
DOI:
10.1002/mds.26796
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center